Stocks · Healthcare · Medical - Care Facilities
Brookdale Senior Living Inc. BKD
$10.86 +0.18% Close, Oct 2, 2026 · NYSE · Market cap $2.59B
Inexpensive vs sectorLow risk
Next earnings report: Nov 5, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- The stock is in a downtrend: below its 200-day average, with the 50-day average below the 200-day.
- The stock is 35% below its highest close of the past year.
- Revenue over the last four quarters was $3.02B, down 2.3% from a year earlier, slowing from 3.1% a quarter earlier.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 27%
- FCF growth (TTM, YoY)Top 35%
- Revenue growth, 3-year CAGRBottom 36%
- Revenue growth accelerationBottom 24%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 29%
- Gross marginBottom 12%
- Operating marginTop 36%
- Accruals (lower is better)Bottom 48%
- Net debt / EBITDA (lower is better)Top 47%
- Interest coverTop 42%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 44%
- Free-cash-flow yieldTop 33%
- EBITDA / enterprise valueTop 2%
- Sales / enterprise valueTop 12%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 38%
- 6-month returnBottom 22%
- 1-year return vs S&P 500Top 39%
- Distance from 52-week highBottom 44%
- Trend checklist (0–4)Bottom 14%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 17%
- Consecutive EPS beatsBottom 49%
- Share of analysts rating BuyBottom 23%
- Upside to consensus price targetTop 46%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 17%
- Maximum drawdown, 3 yearsTop 17%
- Beta vs S&P 500 (lower is better)Top 2%
- Net debt / EBITDA (lower is better)Top 47%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 3.1% | -2.3% | ↓ |
| Gross margin | 27.1% | 14.4% | ↓ |
| Operating margin | 1.7% | 3.8% | ↑ |
| FCF margin | 0.6% | 0.8% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | -2.3% | 3.1% | ↓ | Bottom 27% |
| Gross margin | 14.4% | 27.1% | ↓ | Bottom 12% |
| Operating margin | 3.8% | 1.7% | ↑ | Top 36% |
| Net margin | -4.6% | -7.9% | ↑ | — |
| Free-cash-flow margin | 0.8% | 0.6% | ↑ | — |
| Return on invested capital | 2.0% | — | Top 29% | |
| Revenue growth, 3-year CAGR | 4.4% | — | Bottom 36% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -6.1%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 0.4%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +3.0 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 1.04×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 0.6×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- 0.07%
- Shareholder yield
- 0.07%
- Share count change, 1 year
- +4.8%
- Share count change, 3-year CAGR
- +2.7%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 10, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 1
- Beats in the last 8 reports
- 1 of 8
- Average EPS surprise, last 4
- -31.5%
- Average 2-day reaction, last 8
- -2.0%
- Positive 20 days after report
- 2 of 8
Analysts
- Consensus price target
- $19.00
- Target vs current price
- +75.0%
- Analysts with a rating
- 12
- Share rating Buy or Strong Buy
- 58%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 10, 2026 | +280.2% | -3.7% | -11.1% | -17.2% | — |
| May 6, 2026 | -200.0% | +1.1% | -7.5% | -12.7% | +4.1% |
| Feb 18, 2026 | -6.3% | -0.5% | -7.7% | -12.6% | -22.7% |
| Nov 6, 2025 | -200.0% | -1.7% | +13.4% | +14.8% | +70.9% |
| Aug 6, 2025 | -28.6% | -1.0% | -8.2% | -3.2% | +13.6% |
| May 6, 2025 | -154.5% | +1.8% | +3.2% | -0.5% | +16.9% |
| Feb 18, 2025 | -131.3% | -0.2% | +6.2% | +15.8% | +30.3% |
| Nov 7, 2024 | -29.4% | -11.8% | -15.8% | -13.3% | -27.4% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 10, 2026 | $0.10 | -$0.06 | +280.2% | $718.6M |
| May 6, 2026 | -$0.03 | $0.03 | -200.0% | $764.9M |
| Feb 18, 2026 | -$0.17 | -$0.16 | -6.3% | $754.1M |
| Nov 6, 2025 | -$0.48 | -$0.16 | -200.0% | $813.2M |
| Aug 6, 2025 | -$0.18 | -$0.14 | -28.6% | $812.9M |
| May 6, 2025 | -$0.28 | -$0.11 | -154.5% | $813.9M |
| Feb 18, 2025 | -$0.37 | -$0.16 | -131.3% | $780.9M |
| Nov 7, 2024 | -$0.22 | -$0.17 | -29.4% | $784.2M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (forward) | 325.8× | — | — | — |
| EV / EBITDA | 4.0× | — | — | Top 2% |
| EV / Sales | 1.16× | — | — | Top 12% |
| Free-cash-flow yield | 0.91% | — | — | Top 33% |
| Earnings yield | -5.33% | — | — | Top 44% |
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -10.5%
- 200-day average slope (20 days)
- +0.6%
- Distance from 50-day average
- -12.9%
- Distance from 200-day average
- -18.9%
- RSI (14)
- 24.7
- Relative volume
- 1.61×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 35.9%
- Volatility vs own 5-year history
- 15th percentile · Low for this stock
- Beta vs S&P 500 (2 years, weekly)
- -0.08
- Correlation with S&P 500
- -0.03
- Current drawdown from 1-year high
- -35.2%
- Maximum drawdown, 3 years
- -43.6%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Jun 16, 2021 | Mar 23, 2023 | -73.1% | 445 days | 639 days (Oct 9, 2025) |
| Feb 11, 2026 | Sep 30, 2026 | -35.4% | 159 days | Not yet recovered |
| Oct 23, 2020 | Nov 5, 2020 | -20.3% | 9 days | 2 days (Nov 9, 2020) |
| Mar 15, 2021 | Mar 24, 2021 | -17.2% | 7 days | 10 days (Apr 8, 2021) |
| Nov 24, 2020 | Dec 11, 2020 | -15.8% | 12 days | 21 days (Jan 13, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $2.59B
- EPS, diluted (TTM)
- -$0.58
- Revenue (TTM)
- $3.02B
- 52-week range
- $7.97 – $17.09
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $2.75B | $2.74B | $2.87B | $2.98B | $3.12B |
| Gross profit | $488.6M | $513.9M | $744.7M | $807.4M | $645.0M |
| Operating income | -$216.9M | -$42.7M | $18.4M | $46.5M | $17.2M |
| Net income | -$99.3M | -$238.4M | -$189.0M | -$201.9M | -$262.7M |
| EPS (diluted) | -$0.54 | -$1.25 | -$0.84 | -$0.89 | -$1.11 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $746.4M | $747.0M | $780.1M | $812.9M | $777.8M | $754.1M | $764.9M | $718.6M |
| Net income | -$50.7M | -$83.9M | -$65.0M | -$43.0M | -$114.7M | -$40.0M | -$6.9M | $23.3M |
| EPS (diluted) | -$0.22 | -$0.37 | -$0.28 | -$0.18 | -$0.48 | -$0.17 | -$0.03 | $0.10 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$94.6M | $3.3M | $162.9M | $166.2M | $218.0M |
| Capital expenditure | -$176.7M | -$196.9M | -$233.2M | -$200.6M | -$201.5M |
| Free cash flow | -$271.3M | -$193.6M | -$70.3M | -$34.4M | $16.5M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | -$4.8M | $139.4M | -$1.9M | -$3.4M | -$6.5M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $390.3M
- Total assets
- $5.90B
- Total liabilities
- $5.93B
- Total debt
- $1.29B
- Net debt
- $918.8M
- Shareholders’ equity
- -$29.0M
As of Jun 30, 2026 (filed Aug 10, 2026).
Dividends
| Ex-date | Amount | Paid |
|---|---|---|
| Oct 8, 2008 | $0.25 | Oct 17, 2008 |
| Jul 2, 2008 | $0.25 | Jul 15, 2008 |
| Mar 27, 2008 | $0.25 | Apr 14, 2008 |
| Dec 27, 2007 | $0.50 | Jan 14, 2008 |
| Sep 26, 2007 | $0.50 | Oct 12, 2007 |
| Jun 27, 2007 | $0.50 | Jul 13, 2007 |
| Mar 28, 2007 | $0.45 | Apr 13, 2007 |
| Dec 27, 2006 | $0.45 | Jan 15, 2007 |
Short interest
- Shares sold short
- 45,328,780
- Days to cover
- 10.18
- Change vs previous report
- +11.2%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Apr 8, 2015
- 5-for-6